Skip to main content

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 4))

Abstract

Evaluating the clinical utility of diagnostic radiopharmaceuticals is a complicated process, considering — among other things — adverse reactions, radiation dose, stability in vitro and in vivo, drug interaction, pharmacokinetics, costs, acceptability and clinical efficacy. The latter point is the main subject of this paper, which aims at defining a logic structure for clinical evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Campbell EJM. Basic science, science, and medical education. Lancet 1976; i: 134–136.

    Article  Google Scholar 

  2. Editorial. The value of diagnostic tests. Lancet 1979; i: 809–810.

    Google Scholar 

  3. Duszynsky DO, Kuhn JP, Afshani E, Riddlesberger MM jr. Early radionuclide diagnosis of acute osteomyelitis. Radiology 1975; 117: 337–340.

    Google Scholar 

  4. McNeil BJ, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. N Engl J Med 1975; 293: 211–215.

    Article  PubMed  CAS  Google Scholar 

  5. McNeil BJ, Adelstein SJ. Determining the value of diagnostic screening tests. J Nucl Med 1976; 17: 439–448.

    PubMed  CAS  Google Scholar 

  6. Vecchio TJ. Predictive value of a single diagnostic test in unselected populations. N Engl J Med 1966; 274: 1171–1173.

    Article  PubMed  CAS  Google Scholar 

  7. Metz CE. Basic principles of ROC analysis. Sem Nucl Med 1978; 8: 283–298.

    Article  CAS  Google Scholar 

  8. Lusted LB. General problems in medical decision making with comments on ROC analysis. Sem Nucl Med 1978; 8: 299–306.

    Article  CAS  Google Scholar 

  9. Koran LM. The reliability of clinical methods, data and judgement (First of two parts). N Engl J Med 1975; 293: 642–646.

    Article  PubMed  CAS  Google Scholar 

  10. Schwartz WB, Gorry GA, Kassirer JP et a 1. Decision analysis and clinical judgement. Am J Med 1973; 55: 459–472.

    Article  PubMed  CAS  Google Scholar 

  11. Pauker SG, Kassirer JP. Therapeutic decision making: A costbenefit analysis. N Engl J Med 1975; 293: 229–234.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Dige-Petersen, H. (1984). Evaluation of Clinical Information. In: Kristensen, K., Nørbygaard, E. (eds) Safety and efficacy of radiopharmaceuticals. Developments in Nuclear Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6753-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6753-3_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-6755-7

  • Online ISBN: 978-94-009-6753-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics